Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice
Veena Taneja
Department of Immunology, Mayo Clinic, Rochester, MN, USA.
Search for more papers by this authorChella S. David
Department of Immunology, Mayo Clinic, Rochester, MN, USA.
Search for more papers by this authorVeena Taneja
Department of Immunology, Mayo Clinic, Rochester, MN, USA.
Search for more papers by this authorChella S. David
Department of Immunology, Mayo Clinic, Rochester, MN, USA.
Search for more papers by this authorAbstract
Summary: Predisposition to develop rheumatoid arthritis (RA) has been associated with certain human leukocyte antigen (HLA) class II molecules, although the mechanism is still unknown. Various experimental animal models of inflammatory arthritis have been studied to address the role of major histocompatibility complex (MHC) genes in pathogenesis. We have generated transgenic mice expressing HLA class II molecules (DR and DQ) lacking complete endogenous class II molecules to study the interactions involved between class II molecules (DQ and DR) and to define the immunologic mechanisms in inflammatory arthritis. The HLA transgene can positively select CD4+ T cells expressing various Vβ T-cell receptors, and a peripheral tolerance is maintained to transgenic HLA molecules. The expression of HLA molecules on various cells in these mice is similar to that known in humans. In this review, we describe collagen-induced arthritis as a model for human inflammatory arthritis using these transgenic mice. The transgenic mice carrying RA-susceptible haplotype develop gender-biased inflammatory arthritis with clinical and histopathological similarities to RA. Our studies show that polymorphism of HLA class II genes determine the predisposition to rheumatoid/inflammatory arthritis and the epistatic interactions between HLA-DQ and HLA-DR molecules dictate the severity, progression, and modulation of the disease.
References
- 1 Willkens RF, Nepom GT, Marks CR, Nettles JW, Nepom BS. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the “shared epitope” hypothesis. Arthritis Rheum 1991; 34: 43–47.
- 2 Yelamos J, et al. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 1993; 36: 811–814.
- 3 Taneja V, Giphart MJ, Verduijn W, Naipal A, Malaviya AN, Mehra NK. Polymorphism of HLA-DRB, -DQA1, and -DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001. Hum Immunol 1996; 46: 35–41.
- 4 Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–1213.
- 5 Taneja V, Mehra NK, Kailash S, Anand C, Malaviya AN. Protective & risk DR phenotypes in Asian Indian patients with rheumatoid arthritis. Indian J Med Res 1992; 96: 16–23.
- 6 Winchester R, Dwyer E, Rose S. The genetic basis of rheumatoid arthritis. The shared epitope hypothesis. Rheum Dis Clin North Am 1992; 18: 761–783.
- 7 Sattar MA, Al-Saffar M, Guindi RT, Sugathan TN, Behbehani K. Association between HLA-DR antigens and rheumatoid arthritis in Arabs. Ann Rheum Dis 1990; 49: 147–149.
- 8 Gonzalez A, Nicovani S, Massardo L, Bull P, Rodriguez L, Jacobelli S. Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis. Arthritis Rheum 1992; 35: 282–289.
- 9 Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992; 148: 249–258.
- 10 Singal DP, D’Souza M, Reid B, Bensen WG, Kassam YB, Adachi JD. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet 1987; 2: 1118–1120.
- 11 Lanchbury JS, Sakkas LI, Marsh SG, Bodmer JG, Welsh KI, Panayi GS. HLA-DQ beta 3.1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis. Hum Immunol 1989; 26: 59–71.
- 12 Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992; 117: 801–806.
- 13 Ploski R, Mellbye OJ, Ronningen KS, Forre O, Thorsby E. Seronegative and weakly seropositive rheumatoid arthritis differ from clearly seropositive rheumatoid arthritis in HLA class II associations. J Rheumatol 1994; 21: 1397–1402.
- 14 Van Der Horst-Bruinsma IE, Visser H, Hazes JM, Breedveld FC, Verduyn W, Schreuder GM, et al. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol 1999; 60: 152–158.
- 15 Salvat S, et al. Tolerance to a self-peptide from the third hypervariable region of HLA DRB1*0401 in rheumatoid arthritis patients and normal subjects. J Immunol 1994; 153: 5321–5329.
- 16 Zhou G, Garofalo S, Mukhopadhyay K, Lefebvre V, Smith CN, Eberspaecher H, et al. A 182 bp fragment of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J Cell Sci 1995; 108: 3677–3684.
- 17 Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995; 96: 2859–2869.
- 18 Kempson GE, Muir H, Pollard C, Tuke M. The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta 1973; 297: 456–472.
- 19 Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989; 32: 1087–1092.
- 20 Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA 1989; 86: 636–640.
- 21 Andriopoulos NA, Mestecky J, Miller EJ, Bradley EL. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum 1976; 19: 613–617.
- 22 Clague RB, Shaw MJ, Holt PJ. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann Rheum Dis 1980; 39: 201–206.
- 23 Wooley PH, Luthra HS, Singh SK, Huse AR, Stuart JM, David CS. Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc 1984; 59: 737–743.
- 24 Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977; 146: 857–868.
- 25 Stuart JM, Cremer MA, Kang AH, Townes AS. Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum 1979; 22: 1344–1351.
- 26 Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980; 283: 666–668.
- 27 Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981; 154: 688–700.
- 28 Gonnerman W, Cathcart E, Hayes K, Angello V, Lazzari A, Franzblau C. Anticollagen antibody specificity in arthritic nonhuman primates. Arthritis Rheum 1984; 27S: 581.
- 29 Wooley PH, Luthra HS, Lafuse WP, Huse A, Stuart JM, David CS. Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera. J Immunol 1985; 134: 2366–2374.
- 30 Gonzalez-Gay MA, et al. Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis. J Exp Med 1994; 180: 1559–1564.
- 31 Taneja V, Hansen J, Smart M, Griffiths M, Luthra H, David CS. Expression of the H2-E molecule mediates protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: role of cytokines. Int Immunol 1997; 9: 1213–1219.
- 32 Gonzalez-Gay MA, et al. Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics 1995; 42: 35–40.
- 33 Zanelli E, Gonzalez-Gay MA, David CS. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 1995; 16: 274–278.
- 34 Banerjee S, Haqqi TM, Luthra HS, Stuart JM, David CS. Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med 1988; 167: 832–839.
- 35 Haqqi TM, Anderson GD, Banerjee S, David CS. Restricted heterogeneity in T-cell antigen receptor V beta gene usage in the lymph nodes and arthritic joints of mice. Proc Natl Acad Sci USA 1992; 89: 1253–1255.
- 36 Moder KG, Luthra HS, Kubo R, Griffiths M, David CS. Prevention of collagen induced arthritis in mice by treatment with an antibody directed against the T cell receptor alpha beta framework. Autoimmunity 1992; 11: 219–224.
- 37 Moder KG, Luthra HS, Griffiths M, David CS. Prevention of collagen induced arthritis in mice by deletion of T cell receptor V beta 8 bearing T cells with monoclonal antibodies. Br J Rheumatol 1993; 32: 26–30.
- 38 Schluter SF, Adelman MK, Taneja V, David C, Yocum DE, Marchalonis JJ. Natural autoantibodies to TCR public idiotopes: potential roles in immunomodulation. Cell Mol Biol (Noisy-le-grand) 2003; 49: 193–207.
- 39 Taneja V, David CS. HLA class II transgenic mice as models of human diseases. Immunol Rev 1999; 169: 67–79.
- 40 Taneja V, Griffiths MM, Luthra H, David CS. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism. Int Immunol 1998; 10: 1449–1457.
- 41 Taneja V, David CS. Lessons from animal models for human autoimmune diseases. Nat Immunol 2001; 2: 781–784.
- 42 Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, et al. Mice lacking MHC class II molecules. Cell 1991; 66: 1051–1066.
- 43 Geluk AT, et al. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc Natl Acad Sci USA 1998; 95: 10797–10802.
- 44 DaSilva L, Welcher BC, Ulrich RG, Aman MJ, David CS, Bavari S. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis 2002; 185: 1754–1760.
- 45 Infante AJ, et al. Evidence of a diverse T cell receptor repertoire for acetylcholine receptor, the autoantigen of myasthenia gravis. J Autoimmun 2003; 21: 167–174.
- 46 Cheng S, et al. Expression and function of HLA-DQ8 (DQA1*0301/DQB1*0302) genes in transgenic mice. Eur J Immunogenet 1996; 23: 15–20.
- 47 Nabozny GH, et al. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med 1996; 183: 27–37.
- 48 Bradley DS, et al. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest 1997; 100: 2227–2234.
- 49 Bradley DS, Das P, Griffiths MM, Luthra HS, David CS. HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polychondritis. J Immunol 1998; 161: 5046–5053.
- 50 Bardos T, Zhang J, Mikecz K, David CS, Glant TT. Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age. Arthritis Rheum 2002; 46: 2465–2475.
- 51 Krco CJ, Watanabe S, Harders J, Griffths MM, Luthra H, David CS. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice. J Immunol 1999; 163: 1661–1665.
- 52 Matsushita S, et al. HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes. Int Immunol 1996; 8: 757–764.
- 53 Hjelmstrom P, DeWeese-Scott C, Penzotti JE, Lybrand TP, Sanjeevi CB. Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling. J Neuroimmunol 1998; 85: 102–205.
- 54 Steele JC, Young SP, Goodall JC, Gallimore PH. Structural aspects of the interaction between heterogeneic human papillomavirus type 1 E4-specific T cell receptors and the same peptide/HLA-DQ8 complex. J Immunol 1998; 161: 4745–4752.
- 55 Zanelli E, Krco CJ, David CS. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition. J Immunol 1997; 158: 3545–3551.
- 56 Chicz RM, Lane WS, Robinson RA, Trucco M, Strominger JL, Gorga JC. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int Immunol 1994; 6: 1639–1649.
- 57 Kwok WW, Domeier ML, Raymond FC, Byers P, Nepom GT. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J Immunol 1996; 156: 2171–2177.
- 58 Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273–280.
- 59 Zanelli E, Krco CJ, Baisch JM, Cheng S, David CS. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci USA 1996; 93: 1814–1819.
- 60 Fitzgerald JE, et al. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1995; 154: 3538–3547.
- 61 Gonzalez-Quintial R, Baccala R, Pope RM, Theofilopoulos AN. Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J Clin Invest 1996; 97: 1335–1343.
- 62 Holoshitz J, Koning F, Coligan JE, De Bruyn J, Strober S. Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 1989; 339: 226–229.
- 63 He X, Kang AH, Stuart JM. Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2000; 27: 589–593.
- 64 Taneja V, et al. CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol 2002; 168: 5867–5875.
- 65 Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7− CD28− T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996; 97: 2027–2037.
- 66 Taneja V, Taneja N, Behrens M, Griffiths MM, Luthra HS, David CS. Requirement for CD28 may not be absolute for collagen-induced arthritis: study with HLA-DQ8 transgenic mice. J Immunol 2005; 174: 1118–1125.
- 67 Taneja V, Krco CJ, Behrens MD, Luthra HS, Griffiths MM, David CS. B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice. Mol Immunol 2007; 44: 2988–2996.
- 68 Mangalam AK, Rajagopalan G, Taneja V, David CS. HLA class II transgenic mice mimic human inflammatory diseases. Adv Immunol 2008; 97: 65–147.
- 69 Gonzalez-Gay MA, et al. Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. Hum Immunol 1996; 50: 54–60.
- 70 Pan S, Trejo T, Hansen J, Smart M, David CS. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response. J Immunol 1998; 161: 2925–2929.
- 71 Madsen L, et al. Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci USA 1999; 96: 10338–10343.
- 72 Taneja V, et al. Delineating the role of the HLA-DR4 “shared epitope” in susceptibility versus resistance to develop arthritis. J Immunol 2008; 181: 2869–2877.
- 73 Das P, Bradley DS, Geluk A, Griffiths MM, Luthra HS, David CS. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Hum Immunol 1999; 60: 575–582.
- 74 Pan S, Taneja V, Griffiths MM, Luthra H, David CS. Complementation between HLA-DR4 (DRB1*0401) and specific H2-A molecule in transgenic mice leads to collagen-induced arthritis. Hum Immunol 1999; 60: 816–825.
- 75 Taneja V, et al. HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (DW4) transgenic mice from arthritis. J Immunol 2003; 171: 4431–4438.
- 76 Geijsen N, Koenderman L, Coffer PJ. Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. Cytokine Growth Factor Rev 2001; 12: 19–25.
- 77 Eyles JL, Roberts AW, Metcalf D, Wicks IP. Granulocyte colony-stimulating factor and neutrophils--forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol 2006; 2: 500–510.
- 78 Asaga H, Yamada M, Senshu T. Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 1998; 243: 641–646.
- 79 Inagaki M, Takahara H, Nishi Y, Sugawara K, Sato C. Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J Biol Chem 1989; 264: 18119–18127.
- 80 Senshu T, Akiyama K, Nagata S, Watanabe K, Hikichi K. Peptidylarginine deiminase in rat pituitary: sex difference, estrous cycle-related changes, and estrogen dependence. Endocrinology 1989; 124: 2666–2670.